Boston Therapeutics Inc (OTCBB - OTCQB:BTHE)

0.40
Data as of 1:12pm ET
 -0.0287 / -6.69%
Today’s Change
0.38
Today|||52-Week Range
1.67
-71.83%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$16.5M

Company Description

Boston Therapeutics, Inc. is a pharmaceutical company, which engages in the development, manufacture, and commercialization of novel compounds based on complex carbohydrate chemistry. Its products include therapeutic modules such as BTI320, Ipoxyn, and Oxyfex. The company was founded by David Platt and Kenneth A. Tassey Jr. on August 24, 2009 and is headquartered in Manchester, NH.

Contact Information

Boston Therapeutics, Inc.
1750 Elm Street
Manchester New Hampshire 03104
P:(603) 935-9799
Investor Relations:

Employees

Shareholders

Individual stakeholders42.43%
Mutual fund holders--
Other institutional--

Top Executives

David PlattChairman, Chief Executive Officer & Treasurer
Louise GelinasDirector-Business Operations
Anthony Don SquegliaChief Financial & Accounting Officer
Benjamin RivnayChief Scientist
Eric HobermanManager-Clinical Affairs

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.